Hospira to Present at UBS Global Life Sciences Conference Sept. 23
16 Setembro 2009 - 4:41PM
PR Newswire (US)
LAKE FOREST, Ill., Sept. 16 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP), a leading global specialty pharmaceutical and
medication delivery company, today announced that the company will
present at the UBS Global Life Sciences Conference on Wednesday,
Sept. 23, 2009 in New York. The presentation is scheduled to begin
at 8:30 a.m. Eastern time on Wednesday, Sept. 23, 2009. It will be
available to all interested parties through a live audiocast
accessible via the investor relations section of Hospira's Web site
at http://www.hospirainvestor.com/. Listeners should log on
approximately 10 minutes in advance to ensure proper computer setup
to receive the audiocast. The slides accompanying the presentation
will be available on the Hospira Web site. A replay of the webcast
will be available on the Hospira Web site approximately 24 hours
after the live presentation for 30 days after the event. About
Hospira Hospira, Inc. is a global specialty pharmaceutical and
medication delivery company dedicated to Advancing Wellness(TM). As
the world leader in specialty generic injectable pharmaceuticals,
Hospira offers one of the broadest portfolios of generic acute-care
and oncology injectables, as well as integrated infusion therapy
and medication management solutions. Through its products, Hospira
helps improve the safety, cost and productivity of patient care.
The company is headquartered in Lake Forest, Ill., and has
approximately 14,000 employees. Learn more at
http://www.hospira.com/.
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO
http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT:
Media, Stacey Eisen, +1-224-212-2276, or Financial Community, Karen
King, +1-224-212-2711, both of Hospira Web Site:
http://www.hospira.com/ http://www.hospirainvestor.com/
Copyright